Patents by Inventor David C. Benjamin

David C. Benjamin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8457942
    Abstract: Systems and methods for parallel, discrete, simulations include functional capabilities to incorporate one or more human operators or actors into the simulation process. Such individuals can be presented situations where one or more decisions are necessary with respect to ongoing events. Entered decisions are incorporated into simulated events and activities being simulated. These in turn influence the behavior of those entities and also initiate the occurrence of other time-based processes. An architecture artifact or product can be automatically created or updated by recording how a sequence of events took place. The creation of sections of the DoDAF OV-6C Operational Event Trace architectural diagram, for the executable architecture model, can be automatically performed to dynamically provide event traces in response to a live exercise.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: June 4, 2013
    Assignee: Lockheed Martin Corporation
    Inventors: Gregory A. Harrison, Salaheddine Saidi, Russell (Russ) Chan, Ann N. McCauslin, Howard S. Kern, Jeffrey S. Coffin, David C. Benjamin, Lawrence G. Elliott, Christopher A. Young, Stephen D. Peckham, Michael D. Stewart, Mark E. Barbustiak
  • Patent number: 4735898
    Abstract: The new method an products recognize human serum albumin, differentiating blood and tissue from human sources from blood and tissue of other animals. The method and products are particularly useful in forensic investigations. First, mice are injected with purified human serum albumin, spleen cells from the mice are fused with cells from a murine myeloma. Resulting hyberdomas are screened on human serum albumin coated plates. Subcloning, stabilizing by culture and continued assays for anti-human albumin activity produces products which recognize and differentiate blood or tissue samples from samples of other species.
    Type: Grant
    Filed: July 16, 1985
    Date of Patent: April 5, 1988
    Assignee: The University of Virginia Alumini Patents Foundation
    Inventors: John C. Herr, David C. Benjamin